You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Tecentriq, Kesimpta lead latest SMC decisions

The Scottish Medicines Consortium (SMC) has accepted three new medicines for use by NHS Scotland and rejected one in its July 2021 decisions.